Cargando…
Design, Synthesis and Biological Evaluation of 4-Benzamidobenzoic Acid Hydrazide Derivatives as Novel Soluble Epoxide Hydrolase Inhibitors
Inhibitors of soluble epoxide hydrolase (sEH) represent one of the novel pharmaceutical approaches for treating hypertension, vascular inflammation, pain and other cardiovascular related diseases. Most of the potent sEH inhibitors reported in literature often suffer from poor solubility and bioavail...
Autores principales: | Rezaee Zavareh, Elham, Hedayati, Mahdi, Hoghooghi Rad, Laleh, Shahhosseini, Soraya, Faizi, Mehrdad, Tabatabai, Sayyed Abbas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977053/ https://www.ncbi.nlm.nih.gov/pubmed/24711829 |
Ejemplares similares
-
Design, Synthesis and Biological Activity of 4,6-disubstituted Pyridin-2(1H)-ones as Novel Inhibitors of Soluble Epoxide Hydrolase
por: Hejazi, Leila, et al.
Publicado: (2019) -
Novel 2-substituted-5-(4-chloro-2-phenoxy)phenyl-1,3,4-oxadiazole derivatives, ligands of GABAA/benzodiazepine receptor complex: Design, synthesis, radioligand binding assay, and pharmacological evaluation
por: Rezaee, Elham, et al.
Publicado: (2023) -
Optimum Conditions of Radioligand Receptor Binding Assay of Ligands of Benzodiazepine Receptors
por: Ahmadi, Fatemeh, et al.
Publicado: (2014) -
Evaluation of Anxiolytic, Sedative-hypnotic and Amnesic Effects of Novel 2-phenoxy phenyl-1,3,4-oxadizole Derivatives Using Experimental Models
por: Tabatabai, Sayyed Abbas, et al.
Publicado: (2015) -
Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)